Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

from Health & Medicine News -- ScienceDaily https://ift.tt/3hpjKKi

Comments

Post a Comment

Popular posts from this blog

New target to improve response to cancer immunotherapy

Researchers have looked at a little-understood type of cell death called ferroptosis. They found ferroptosis occurs in tumor cells and plays a role in cancer immunity, suggesting the potential of targeting this pathway to improve immunotherapy treatments. from Health & Medicine News -- ScienceDaily http://bit.ly/2Lka6wC
Read more

New 3D imaging and visualization technique provides detailed views of muscle architecture

In a new study, scientists in pathology and anatomical sciences have revealed a three-dimensional view of the skeletal muscles responsible for flight in a European starling. The study will form the basis of future research on the bird's wishbone, which is supported by these particular muscles and is hypothesized to bend during flight. from Health & Medicine News -- ScienceDaily http://bit.ly/2Lg1pU1
Read more